The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
SLEEPR
1 other identifier
observational
200
1 country
6
Brief Summary
Sleep is critical for health and quality of life; however, little is known about the prevalence or impact of non obstructive sleep apnea (non-OSA) sleep disorders in people with stroke. The proposed study aims to characterize the proportion of people with stroke that have non-OSA sleep disorders and their impact on recovery of activities of daily living, functional mobility, and participation along the continuum of recovery in people with stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 25, 2021
CompletedFirst Submitted
Initial submission to the registry
August 9, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMay 22, 2024
May 1, 2024
3.9 years
August 9, 2021
May 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (17)
Functional independence with activities of daily living as measured by the Barthel index
The Barthel index is a measure of functional independence with activities of daily living; the score range is 0-100 with higher numbers indicating more independence
15 days post-stroke
Functional independence with activities of daily living as measured by the Barthel index
The Barthel index is a measure of functional independence with activities of daily living; the score range is 0-100 with higher numbers indicating more independence
60 days post-stroke
Functional independence with activities of daily living as measured by the Barthel index
The Barthel index is a measure of functional independence with activities of daily living; the score ranges 0-100 with higher numbers indicating more independence
90 days post-stroke
Level of disability according to the stroke impact scale
The stroke impact scale is a self-report measure of disability; scores range from 0-100 with higher numbers indicating better function
60 days post-stroke
Level of disability according to the stroke impact scale
The stroke impact scale is a self-report measure of disability; scores range from 0-100 with higher numbers indicating better function
90 days post-stroke
Daytime sleepiness according to the Epworth Sleepiness Scale
Epworth sleepiness scale is a self report measure describing likelihood of falling asleep during different circumstances; scores range from 0-24, with higher numbers indicating more sleepiness
15 days post-stroke
Daytime sleepiness according to the Epworth Sleepiness Scale
Epworth sleepiness scale is a self report measure describing likelihood of falling asleep during different circumstances; scores range from 0-24, with higher numbers indicating more sleepiness
60 days post-stroke
Daytime sleepiness according to the Epworth Sleepiness Scale
Epworth sleepiness scale is a self report measure describing likelihood of falling asleep during different circumstances; scores range from 0-24, with higher numbers indicating more sleepiness
90 days post-stroke
Insomnia severity as determined from the insomnia severity index
The insomnia severity index is a self report measure of insomnia severity; scores range from 0-28, with higher numbers indicating more severe insomnia
15 days post-stroke
Insomnia severity as determined from the insomnia severity index
The insomnia severity index is a self report measure of insomnia severity; scores range from 0-28, with higher numbers indicating more severe insomnia
60 days post-stroke
Insomnia severity as determined from the insomnia severity index
The insomnia severity index is a self report measure of insomnia severity; scores range from 0-28, with higher numbers indicating more severe insomnia
90 days post-stroke
Likely presence of restless legs syndrome as measured by the Cambridge Hopkins restless legs questionnaire
The Cambridge Hopkins restless legs questionnaire is a self report measure of presence and frequency of symptoms of restless legs syndrome; responses are scored according to an algorithm that provides yes/no for likely presence of restless legs syndrome.
15 days post-stroke
Likely presence of restless legs syndrome as measured by the Cambridge Hopkins restless legs questionnaire
The Cambridge Hopkins restless legs questionnaire is a self report measure of presence and frequency of symptoms of restless legs syndrome; responses are scored according to an algorithm that provides yes/no for likely presence of restless legs syndrome.
60 days post-stroke
Likely presence of restless legs syndrome as measured by the Cambridge Hopkins restless legs questionnaire
The Cambridge Hopkins restless legs questionnaire is a self report measure of presence and frequency of symptoms of restless legs syndrome; responses are scored according to an algorithm that provides yes/no for likely presence of restless legs syndrome.
90 days post-stroke
Cumulative morbidity of sleep disorders, as determined from the sleep disorders checklist, 25 item version
The sleep disorders checklist, 25 item version, is a self report questionnaire of frequency of occurrence of 25 sleep disorder symptoms; scores range from 0-100, with higher numbers indicating worse overall morbidity of sleep disorders.
15days post-stroke
Cumulative morbidity of sleep disorders, as determined from the sleep disorders checklist, 25 item version
The sleep disorders checklist, 25 item version, is a self report questionnaire of frequency of occurrence of 25 sleep disorder symptoms; scores range from 0-100, with higher numbers indicating worse overall morbidity of sleep disorders.
60days post-stroke
Cumulative morbidity of sleep disorders, as determined from the sleep disorders checklist, 25 item version
The sleep disorders checklist, 25 item version, is a self report questionnaire of frequency of occurrence of 25 sleep disorder symptoms; scores range from 0-100, with higher numbers indicating worse overall morbidity of sleep disorders.
90 days post-stroke
Secondary Outcomes (31)
Degree of disability according to the modified Rankin scale
15 days post-stroke
Degree of disability according to the modified Rankin scale
60 days post-stroke
Degree of disability according to the modified Rankin scale
90 days post-stroke
Balance ability according to the Berg balance scale
15 days post-stroke
Balance ability according to the Berg balance scale
60 days post-stroke
- +26 more secondary outcomes
Study Arms (1)
SLEEPR cohort
Individuals within first 3 months following stroke who did not have obstructive sleep apnea within the first 15 days following stroke
Interventions
Eligibility Criteria
Adults recovering from stroke within the first 90 days following stroke who did not have a diagnosis of obstructive sleep apnea (OSA) prior to stroke or who do not have oxygen desaturation index (ODI) of 15 or higher during inpatient rehabilitation (\~15 days post-stroke).
You may qualify if:
- Diagnosis of stroke as defined by the WHO: "a rapid onset event of vascular origin reflecting a focal disturbance of cerebral function, excluding isolated impairments of higher function and persisting longer than 24 hours." Diagnosis of stroke will be confirmed by imaging or clinical diagnosis.
- Age 18 or older.
- Admitted to in-patient rehabilitation.
- National Institutes of Health Stroke Scale (NIHSS) item 1a score \<2 (Level of consciousness: 0=alert, 1=not alert, but arousable by minor stimulation to obey, answer, or respond).
- Provision of informed consent by individual or by legally authorized representative.
You may not qualify if:
- Pre-stroke or current diagnosis of OSA or other sleep-related breathing disorder.
- Living in a nursing home or assisted living center prior to the stroke.
- Unable to ambulate 150' independently prior to the stroke.
- Other neurologic health condition that may impact recovery such as Parkinson Disease, Multiple Sclerosis, Traumatic Brain Injury, Alzheimer's Disease.
- Women who are pregnant.
- Recent hemicraniectomy or suboccipital craniectomy (i.e. those whose bone has not yet been replaced), or any other recent bone removal procedure for relief of intracranial pressure.
- Planned discharge location \>150 miles radius from recruitment site
- Global aphasia as defined by a NIHSS item 9 score of 3 (3= Mute, global aphasia; no usable speech or auditory comprehension).
- Inability to understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Emory University
Atlanta, Georgia, 39322, United States
KU Medical Center, The University of Kansas
Kansas City, Kansas, 66160, United States
Institute for Human Performance - Upstate Rehabilitation at IHP
Syracuse, New York, 13210, United States
Upstate University Hospital
Syracuse, New York, 13210, United States
Upstate Community Hospital
Syracuse, New York, 13215, United States
Good Shepherd Rehabilitation Network
Allentown, Pennsylvania, 17193, United States
Related Publications (1)
Klingman KJ, Skufca JD, Duncan PW, Wang D, Fulk GD. Study Protocol: Sleep Effects on Poststroke Rehabilitation Study. Nurs Res. 2022 Nov-Dec 01;71(6):483-490. doi: 10.1097/NNR.0000000000000611. Epub 2022 Aug 6.
PMID: 35948301DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen J Klingman, PhD
SUNY Upstate Medical University, College of Nursing
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 9, 2021
First Posted
August 19, 2021
Study Start
March 25, 2021
Primary Completion
January 30, 2025
Study Completion
June 30, 2025
Last Updated
May 22, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Anticipated availability of the dataset will be announced during the final year of the project, with notification of how to apply for access to the data. Data will be deposited into the institutional repository as soon as possible, after key manuscripts have been accepted for publication. Should manuscripts be delayed due to unforeseen circumstances, data will be available through the repository within a year of project closure. Data will remain available by request from the PI during time of employment at SUNY Upstate, after which time the SUNY Upstate library will manage and grant access according to guidelines set forth by the IRB.
- Access Criteria
- An online data request form will be available so that others can indicate their interest in the data through a publicly available website. A data sharing agreement will be signed by all parties. Because detailed pattern of life information may contain information that may allow subject identity to be recovered, we intend to provide two levels of data sharing with three classes of data. 1. Controlled share: data (to include pattern-of-life data) that contains information for which identity could be recovered if analyzed with malicious intent. These data will only be released to vetted researchers under conditions that provide assurance of protected privacy. 2. Public share: a subset of the variables that are not expected to provide privacy risk; and Geo-summarized or modified data - consistent with state-of-the-art methodologies for differential privacy, the collected participation (geolocation) data will be made available after the data has been modified to preserve privacy.
Final research data along with meta-data and descriptors will be shared to the maximum extent possible while protecting patient privacy. Data will be for individual subjects. No aggregate data will be provided apart from what is published in the literature. Data will be formatted for SPSS and/or as csv files.